X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://recalls-rappels.canada.ca/en/alert-recall/quetiapine-25-mg-affected-lot-quetiapine-25-mg-may-contain-sertraline-50-mg-tablets
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206954
https://www.globenewswire.com/news-release/2021/07/01/2256446/0/en/OWP-Pharmaceuticals-Announces-Patent-Issuance-for-the-First-Ever-Oral-Liquid-Suspension-of-Quetiapine-for-the-Treatment-of-Schizophrenia-and-Bipolar-Disorder.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202228
https://www.prnewswire.com/news-releases/luye-pharma-signs-two-agreements-in-latin-america-global-business-system-for-seroquel-continues-to-grow-rapidly-301128315.html
https://en.prnasia.com/releases/apac/luye-pharma-enters-distribution-and-marketing-partnerships-in-south-korea-hong-kong-and-thailand-for-seroquel-and-seroquel-xr--281473.shtml
https://www.biospectrumasia.com/news/48/16029/luye-pharma-raises-awareness-on-mental-health.html
https://www.pharmacompass.com/pdf/news/history-updates-for-the-enforcement-report-week-of-march-18-2020-1584513978.pdf
https://www.fiercepharma.com/pharma/astrazeneca-to-shell-out-ps12m-severance-dispute-workers-at-former-england-plant
https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2019/astrazeneca-divests-rights-to-seroquel-and-seroquel-xr-in-the-us-and-canada-03122019.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211405
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209497
http://www.pharmatimes.com/news/astrazeneca_settles_seroquelcrestor_lawsuits_for_$110_million_1248068
https://www.biospectrumasia.com/news/48/11343/luye-pharma-receives-china-approval-for-cns-drug.html
https://www.prnewswire.com/news-releases/seroquel-stepping-stone-how-luye-will-use-seroquel-to-expand-in-emerging-markets-300661321.html
http://www.pharmatimes.com/news/astrazeneca_sheds_seroquel_rights_1234663
https://www.biopharmadive.com/news/astrazeneca-sells-off-foreign-rights-to-seroquel/522959/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090757
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209635
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207655
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208947
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204253
http://www.pharmatimes.com/news/az_books_3_percent_sales_drop_for_q3_1210956
https://www.biospectrumasia.com/news/33/9370/generic-seroquel-xr-tablets-launched-by-lupin-in-usa.html
http://www.massdevice.com/integra-lifesciences-johnson-johnson-pass-papers-1b-codman-neuro-buy/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206260
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090482
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202939
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090681
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-arm-in-pact-to-distribute-anti-depressant-drug-in-japan/articleshow/57371270.cms
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206252
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090681
https://globenewswire.com/news-release/2016/10/11/878734/0/en/Intellipharmaceutics-Signs-an-Exclusive-License-and-Commercial-Supply-Agreement-with-Mallinckrodt.html
https://www.pharmacompass.com/pdf/news/intellipharmaceutics-quetiapine-fumarate-approved-in-us-1476274137.pdf
https://globenewswire.com/news-release/2016/10/07/878050/0/en/Intellipharmaceutics-Announces-FDA-Tentative-Approval-for-Generic-Seroquel-XR.html
https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-co-ltd-yantou-campus-fails-edqm-inspection-1483966941.pdf
https://www.pharmacompass.com/pdf/news/macleodss-generic-quetiapine-fumarate-approved-in-us-to-treat-schizophrenia-1463736176.pdf
http://in.reuters.com/article/us-acadia-pharm-fda-idINKCN0XQ2L6
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/unichem-lab-gets-usfda-nod-for-schizophrenia-tablets/articleshow/51329410.cms
https://www.pharmacompass.com/pdf/news/unichem-labs-ltds-generic-quetiapine-fumarate-approved-in-us-to-treat-schizophrenia-1457776995.pdf
http://www.reuters.com/article/us-health-opioid-letters-idUSKCN0W92FD
http://www.business-standard.com/article/markets/unichem-gains-on-usfda-nod-for-quetiapine-fumarate-tablets-116030900499_1.html
http://www.fiercepharma.com/story/patent-losses-looming-az-fights-back-brilinta-diabetes-and-china/2016-02-04
http://www.newsinferno.com/new-study-warns-of-side-effect-risk-in-off-label-drug-prescribing/?
http://www.fiercepharma.com/story/allergan-and-richters-antipsychotic-gets-fda-ok-faces-stiff-competition/2015-09-17
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1141-2015&w=06242015&lang=eng
http://www.nytimes.com/2015/03/02/us/psychiatric-drug-overuse-is-cited-by-federal-study.html?_r=0
Market Place
Share 
